BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Caligan Partners LP's Holding History (CIK: 0001727492)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 638,908 Value ($000) $5,725 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 3,107,669 Value ($000) $23,308 Avg Close $8.07 Range $6.96 - $9.50

Q4 2024

Shares 2,995,932 Value ($000) $22,529 Avg Close $7.59 Range $6.85 - $8.44

Q3 2024

Shares 2,583,585 Value ($000) $19,635 Avg Close $7.60 Range $6.17 - $8.88

Q2 2024

Shares 4,598,737 Value ($000) $28,420 Avg Close $5.52 Range $4.03 - $6.99

Q1 2024

Shares 758,502 Value ($000) $3,853 Avg Close $5.62 Range $4.82 - $7.75

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	638,908	$5,725	$9.31	$6.02 - $11.31
Q1 2025	3,107,669	$23,308	$8.07	$6.96 - $9.50
Q4 2024	2,995,932	$22,529	$7.59	$6.85 - $8.44
Q3 2024	2,583,585	$19,635	$7.60	$6.17 - $8.88
Q2 2024	4,598,737	$28,420	$5.52	$4.03 - $6.99
Q1 2024	758,502	$3,853	$5.62	$4.82 - $7.75